HSD17B13-IN-39
HSD17B13-IN-39 (Compound A) is an inhibitor of hydroxysteroid 17β-dehydrogenase 13 (HSD17B13) . HSD17B13-IN-39 can be used for research on liver diseases, metabolic diseases, or cardiovascular diseases, such as NAFLD or NASH[1].
Product Specifications
UNSPSC
12352005
Target
17β-HSD
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/hsd17b13-in-39.html
Solubility
10 mM in DMSO
Smiles
OC1=CC=CC(C2=C3C=CC(O)=CC3=CC=N2)=C1
Molecular Formula
C15H11NO2
Molecular Weight
237.25
References & Citations
[1]Vincent FLORIO, et al. Substrate selective hsd17b13 inhibitors and uses thereof. WIPO, WO2021211981A1. 2021-10-21.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-157665/HSD17B13-IN-39-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-157665/
Scientific Category
Reference compound1
Clinical Information
No Development Reported
CAS Number
[2730022-55-4]
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
